Top compounds associated with response to LINC00238


Feature Type Standardized
Nominal ANOVA
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.03 0.5
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA AZD-7545 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA PD-0332991 CCLE pan-cancer AAC -0.03 0.5
mRNA bendamustine CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Erlotinib gCSI pan-cancer AAC 0.036 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.034 0.5
mRNA Topotecan CCLE pan-cancer AAC 0.027 0.5
Download CSV